MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3350/cmh.2023.0485

Медицинская библиотека · Clinical and molecular hepatology · 2024

Global incidence of adverse clinical events in non-alcoholic fatty liver disease: A systematic review and meta-analysis.

Le Michael H, Le David M, Baez Thomas C, Dang Hansen, Nguyen Vy H, Lee KeeSeok, Stave Christopher D, Ito Takanori, Wu Yuankai, Yeo Yee Hui, Ji Fanpu, Cheung Ramsey, Nguyen Mindie H

МетаанализСистематический обзорСтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND/AIMS: Nonalcoholic fatty liver disease (NAFLD) is associated with a multitude of adverse outcomes. We aimed to estimate the pooled incidence of NAFLD-related adverse events.

METHODS

We performed a systematic review and meta-analysis of cohort studies of adults with NAFLD to evaluate the pooled incidence of adverse events.

RESULTS

19,406 articles were screened, 409 full-text articles reviewed, and 79 eligible studies (1,377,466 persons) were included. Mean age was 51.47 years and body mass index 28.90 kg/m2. Baseline comorbidities included metabolic syndrome (41.73%), cardiovascular disease (CVD) (16.83%), cirrhosis (21.97%), and nonalcoholic steatohepatitis (NASH) (58.85%). Incidence rate per 1,000 person-years for mortality included: all-cause (14.6), CVD-related (4.53), non-liver cancer-related (4.53), and liver-related (3.10). Incidence for liver-related events included overall (24.3), fibrosis progression (49.0), cirrhosis (10.9), liver transplant (12.0), and hepatocellular carcinoma (HCC) (3.39). Incidence for non-liver events included metabolic syndrome (25.4), hypertension (25.8), dyslipidemia (26.4), diabetes (19.0), CVD (24.77), renal impairment (30.3), depression/anxiety (29.1), and non-liver cancer (10.5). Biopsy-proven NASH had higher incidence of HCC (P=0.043) compared to non-NASH. Higher rates of CVD and mortality were observed in North America and Europe, hypertension and non-liver cancer in North America, and HCC in Western Pacific/Southeast Asia (P<0.05). No significant differences were observed by sex. Time-period analyses showed decreasing rates of cardiovascular and non-liver cancer mortality and increasing rates of decompensated cirrhosis (P<0.05).

CONCLUSION

People with NAFLD have high incidence of liver and non-liver adverse clinical events, varying by NASH, geographic region, and time-period, but not sex.

Для цитирования: Le Michael H, Le David M, Baez Thomas C, Dang Hansen, Nguyen Vy H, Lee KeeSeok, Stave Christopher D, Ito Takanori, Wu Yuankai, Yeo Yee Hui, Ji Fanpu, Cheung Ramsey, Nguyen Mindie H. Global incidence of adverse clinical events in non-alcoholic fatty liver disease: A systematic review and meta-analysis.. Clinical and molecular hepatology. 2024. DOI: 10.3350/cmh.2023.0485.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.